Pinkerneil, M., Hoffmann, M. J., Kohlhof, H., Schulz, W. A., & Niegisch, G. (2016). Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines. Target Oncol.
Style de citation ChicagoPinkerneil, Maria, Michèle J. Hoffmann, Hella Kohlhof, Wolfgang A. Schulz, et Günter Niegisch. "Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines." Target Oncol 2016.
Style de citation MLAPinkerneil, Maria, et al. "Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines." Target Oncol 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.